Inventor
Brandon Wustman
Inventor
San Diego, CA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
Y02ATechnologies for adaptation to climate change12%
C07KPeptides8%
PatentTitleYear
RE048608Method to predict response to pharmacological chaperone treatment of diseases202110,813,921Method to predict response to pharmacological chaperone treatment of diseases202010,064,851Method for the treatment of neurological disorders by enhancing the activity of b-glucocerebrosidase20189,931,353Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases20189,675,627'Dosing regimens for treating and/or preventing cerebral amyloidoses'20179,597,324'Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes'20179,545,397'Method to predict response to pharmacological chaperone treatment of diseases'20179,402,837'Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase'20169,119,845'Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase'20159,095,584'Method to predict response to pharmacological chaperone treatment of diseases'20159,056,101'Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones'20159,044,437'Method for treating alzheimer\'s disease using pharmacological chaperones to increase the activity of gangliosidases'20158,883,813'Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes'20148,592,362'Method to predict response to pharmacological chaperone treatment of diseases'20137,964,617'Methods for treating parkinsons disease and parkinsonism'20117,829,579'Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Patents assigned to AMICUS THERAPEUTICS INC (14)· patent assignee history
2010–2014Based in Princeton, NJ, US· patent location history
2013–2015Patents assigned to WUSTMAN BRANDON (4)· patent assignee history
2013–2021Based in San Diego, CA, US· patent location history
2014Patents assigned to AMACUS THERAPEUTICS INC (1)· patent assignee history
2015Patents assigned to AMICUS THERAPEAUTICS INC (1)· patent assignee history
2015Patents assigned to AMICUS THERAPEUTICS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMICUS THERAPEUTICS INC | 14 | 2010–2021 |
| WUSTMAN BRANDONself | 4 | 2013–2015 |
| AMACUS THERAPEUTICS INC | 1 | 2014 |
| AMICUS THERAPEAUTICS INC | 1 | 2015 |
| AMICUS THERAPEUTICS | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 13 | 2013–2021 |
| Princeton, New Jersey, US | 3 | 2010–2014 |